Stem Cell Therapy for Chronic Pain Management: Review of Uses, Advances, and Adverse Effects

Author:

Chakravarthy Krishnan1

Affiliation:

1. 1 Department of Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital – Harvard Medical School, Boston, MA;3 Johns Hopkins Institute for Nanobiotechnology (INBT), Baltimore MD

Abstract

Background: This review article outlines the recent advances, uses, and adverse effects of cell-based therapy for chronic pain management. Cell based therapies are gaining increasing ground as novel treatment modalities for a variety of pain pathologies that include, but are not limited to, neuropathic pain and degenerative disc disease. As these treatment modalities become more common practice, we have focused our review to provide pain practitioners and other practicing physicians an understanding of the technology and to summarize key clinical data and existing clinical trials that are being pursued by clinical investigators worldwide. Objective: Review of stem cell technology and applications in pain management. Study Design: Narrative review. Methods: The Pubmed NCBI and EMBASE databases was utilized to review published reports of clinical studies reported from 2000 to 2015, and ClinicalTrials.gov (www. clinicaltrials.gov/ct2/search) search function was used to document ongoing clinical trials [keywords: “chronic pain,” “disc pain,” “cell therapy,” “osteoarthritis,” “neuropathic,” “stem cell”] currently active and recruiting patients. Results: Articles were screened by title, abstract, and full article review. They were then analyzed by specific clinical indications and appropriate data were presented based on critical analysis of those articles. Limitations: More studies looking at the systematic use of stem cells in pain management will be required to draw conclusions about the benefits of the technology. Conclusion: Though the data from existing studies look promising for the use of stem cells as a novel therapeutic strategy for discogenic pain, neuropathic pain, and osteoarthritis, additional clinical studies will be needed to validate the benefit of the technology for clinical use. However, we hope that this narrative review will help guide pain physicians in making informed decisions for their patients about the potential of cell-based therapy for treating chronic pain conditions. Key words: Stem cell therapy, chronic pain, clinical trials, disc pain, neuropathic pain, mesenchymal stem cells, osteoarthritis, pain management

Publisher

American Society of Interventional Pain Physicians

Subject

Anesthesiology and Pain Medicine

Cited by 30 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Exploring the Potential of Stem Cell Therapy and Non-Opioid Anesthesia and Pain Reduction: Reducing the Negative Impact on the Individual and Society;European Journal of Medical and Health Research;2024-05-01

2. The Role of Neuroglia in Administrating Nerve Blockers and Anesthesia to Patients;Neuroglia;2024-01-29

3. Ethical and Policy Issues in Practices of Regenerative Medicine for the Treatment of Chronic Pain;Essentials of Regenerative Medicine in Interventional Pain Management;2024

4. Lumbar Facet Joints and Intraarticular Injection of Biologics;Essentials of Regenerative Medicine in Interventional Pain Management;2024

5. Evolution of Regenerative Medicine in Managing Musculoskeletal and Spinal Disorders;Essentials of Regenerative Medicine in Interventional Pain Management;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3